European Neuroendocrine Tumor Society

Organization

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1159/000475526 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
https://doi.org/10.1016/j.jacc.2016.12.030 Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors
https://doi.org/10.1002/mus.880100414 Adynamia episodica hereditaria with myotonia: A non‐inactivating sodium current and the effect of extracellular pH
https://doi.org/10.1111/jne.13318 European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
https://doi.org/10.1007/s00395-008-0739-7 Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction
https://doi.org/10.1093/annonc/mds267 Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://doi.org/10.1200/jco.20.02903 Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations
https://doi.org/10.1016/j.eclinm.2022.101651 Fatigue and cognitive impairment after COVID-19: A prospective multicentre study
https://doi.org/10.1111/jne.13146 European Neuroendocrine Tumor Society ( ENETS ) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
https://doi.org/10.1111/jne.13306 European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for gastroduodenal neuroendocrine tumours ( NETs) G1–G3
https://doi.org/10.1016/j.ijrobp.2009.10.072 Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study
https://doi.org/10.1136/gutjnl-2020-322595 Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
https://doi.org/10.18632/oncotarget.24524 Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms
https://doi.org/10.1111/jne.13309 European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for colorectal neuroendocrine tumours
https://doi.org/10.1159/000351692 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)
https://doi.org/10.1210/jc.2019-00282 Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors
https://doi.org/10.1007/s00259-019-04501-6 Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors
https://doi.org/10.1159/000444803 Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases
https://doi.org/10.1186/1471-2105-8-214 Precise protein quantification based on peptide quantification using iTRAQ™
https://doi.org/10.1002/mdc3.12965 Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience
https://doi.org/10.1159/000494355 Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study
https://doi.org/10.1186/s12885-020-07581-y Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study
https://doi.org/10.1007/s00432-012-1322-z A nine-gene signature predicting clinical outcome in cutaneous melanoma
https://doi.org/10.1016/j.ejca.2016.01.009 Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up
https://doi.org/10.1002/cncr.31079 Neuroendocrine tumors and fibrosis: An unsolved mystery?
https://doi.org/10.1039/c7dt01936j Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC
https://doi.org/10.1007/978-3-540-36719-2 Therapeutic Nuclear Medicine
https://doi.org/10.2967/jnumed.121.263693 Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using 68Ga-PentixaFor PET
https://doi.org/10.1016/j.ebiom.2022.104276 Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study
https://doi.org/10.1186/s12885-019-6000-y Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
https://doi.org/10.7150/thno.30357 The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
https://doi.org/10.1007/s00482-012-1172-2 Medikamentöse Therapie des Fibromyalgiesyndroms
https://doi.org/10.3389/fnhum.2021.644593 Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies
https://doi.org/10.2967/jnumed.117.206631 SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework
https://doi.org/10.1007/s00482-012-1174-0 Ätiologie und Pathophysiologie des Fibromyalgiesyndroms
https://doi.org/10.1007/s00112-016-0147-2 Ernährung und Bewegung von Säuglingen und stillenden Frauen
https://doi.org/10.1038/s41467-021-27639-0 Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling
https://doi.org/10.1089/cbr.2016.2173 First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44 Sc-DOTATOC: A Proof-of-Concept Study
https://doi.org/10.1158/1078-0432.ccr-21-1504 First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
https://doi.org/10.1016/s1470-2045(22)00750-1 Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
https://doi.org/10.3390/cancers13071523 Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors
https://doi.org/10.1159/000499497 Peptide Receptor Radionuclide Therapy as a Novel Treatment for Metastatic and Invasive Phaeochromocytoma and Paraganglioma
https://doi.org/10.1002/mus.27201 Nerve biopsy: Current indications and decision tools
https://doi.org/10.1093/eurjhf/hfr089 Potential Value of Automated Daily Screening of Cardiac Resynchronization Therapy Defibrillator Diagnostics for Prediction of Major Cardiovascular Events: Results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) Study
https://doi.org/10.1117/1.jbo.25.1.015002 Analysis of tissue microstructure with Mueller microscopy: logarithmic decomposition and Monte Carlo modeling
https://doi.org/10.1002/dvdy.46 Staging and normal table of postembryonic development of the clownfish (Amphiprion ocellaris)
https://doi.org/10.1172/jci163612 Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets
https://doi.org/10.1111/jne.13332 European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for appendiceal neuroendocrine tumours ( aNET )
https://doi.org/10.1007/s00259-021-05351-x Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours
https://doi.org/10.1159/000339611 Gastric Mixed Adenoneuroendocrine Carcinoma with a Trilineage Cell Differentiation: Case Report and Review of the Literature
https://doi.org/10.1007/s00259-024-06641-w First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
https://doi.org/10.1038/s41572-024-00508-y Gastric neuroendocrine neoplasms
https://doi.org/10.1016/j.bpg.2023.101860 Updates in the diagnosis and management of small-bowel tumors
https://doi.org/10.1186/s13550-022-00901-2 A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms
https://doi.org/10.1136/jitc-2023-007118 Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
https://doi.org/10.2967/jnumed.121.263177 Prospective Phase II Trial of Prognostication by 68Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
https://doi.org/10.1186/s40644-018-0168-2 Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
https://doi.org/10.3390/ijms26052000 Impact of Dietary Fiber on Inflammation in Humans
https://doi.org/10.1080/0142159x.2022.2137014 Early clinical exposure in undergraduate medical education: A questionnaire survey of 30 European countries
https://doi.org/10.1002/ejhf.2922 Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
https://doi.org/10.1016/j.esmoop.2023.102062 Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
https://doi.org/10.1007/s00761-024-01508-z „Patient-reported outcomes“ in der onkologischen Versorgung – aktuelle Anwendungsfelder und Initiativen der Deutschen Krebsgesellschaft
https://doi.org/10.1097/rlu.0000000000004674 Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
https://doi.org/10.1056/nejmoa2504964 Belzutifan for Advanced Pheochromocytoma or Paraganglioma
https://doi.org/10.1097/pai.0000000000000906 Immunohistochemical Staining With Neuroendocrine Markers is Essential in the Diagnosis of Neuroendocrine Neoplasms of the Esophagogastric Junction
https://doi.org/10.1210/clinem/dgae111 Modified Histopathological Grading Optimizes Prediction of Survival Outcomes in Small Intestinal Neuroendocrine Tumors
https://doi.org/10.1111/jne.70060 Controversies in NEN : An ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms
https://doi.org/10.1007/s00104-014-2911-y Onkologische Langzeitergebnisse nach offener vs. laparoskopischer Rektumkarzinomchirurgie
https://doi.org/10.1016/0277-5379(87)90109-x Clinical pharmacology of sodium butyrate in patients with acute leukemia
https://doi.org/10.1002/mus.880070205 Hypokalemic periodic paralysis: In vitro investigation of muscle fiber membrane parameters
https://doi.org/10.1086/317457 Prevalence of Hypogonadism among Men with Weight Loss Related to Human Immunodeficiency Virus Infection Who Were Receiving Highly Active Antiretroviral Therapy
https://doi.org/10.1210/jc.2010-1587 Effects of a Growth Hormone-Releasing Hormone Analog on Endogenous GH Pulsatility and Insulin Sensitivity in Healthy Men
https://doi.org/10.1007/s00330-017-4803-2 Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
https://doi.org/10.1136/jmg.2007.054965 Molecular characterisation of a common SDHB deletion in paraganglioma patients
https://doi.org/10.1159/000343801 Current Size Criteria for the Management of Neuroendocrine Tumors of the Appendix: Are They Valid? Clinical Experience and Review of the Literature
https://doi.org/10.1053/j.semnuclmed.2016.01.010 Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues
https://doi.org/10.1016/j.parkreldis.2018.06.013 Consensus for the measurement of the camptocormia angle in the standing patient
https://doi.org/10.1159/000457957 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors
https://doi.org/10.1159/000338793 The Role of Cell Lines in the Study of Neuroendocrine Tumors
https://doi.org/10.1111/ajco.12438 Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long‐term outcomes
https://doi.org/10.1007/978-3-642-27994-2_20 Rare Metastases Detected by 68Ga-Somatostatin Receptor PET/CT in Patients with Neuroendocrine Tumors
https://doi.org/10.1245/s10434-014-3981-2 Impact of 68Ga-DOTATATE PET/CT on the Surgical Management of Primary Neuroendocrine Tumors of the Pancreas or Ileum
https://doi.org/10.1007/s11154-017-9438-8 Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
https://doi.org/10.3978/j.issn.2072-1439.2015.04.20 Multidisciplinary management of advanced lung neuroendocrine tumors.
https://doi.org/10.1007/s00482-014-1436-0 Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen?
https://doi.org/10.1158/1535-7163.mct-14-0481 Histone Deacetylase 6 Represents a Novel Drug Target in the Oncogenic Hedgehog Signaling Pathway
https://doi.org/10.1002/mds.27559 Utility and implications of exome sequencing in early‐onset Parkinson's disease
https://doi.org/10.1007/s12149-018-1291-7 Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications
https://doi.org/10.1007/s11154-020-09552-x Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
https://doi.org/10.1182/blood-2007-02-075036 Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas
https://doi.org/10.1093/annonc/mdv620 Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial
https://doi.org/10.1074/jbc.m800963200 The Survival-promoting Peptide Y-P30 Enhances Binding of Pleiotrophin to Syndecan-2 and -3 and Supports Its Neuritogenic Activity
https://doi.org/10.1111/jne.12967 Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms
https://doi.org/10.1136/thoraxjnl-2020-215866 DNA methylation is associated with airflow obstruction in patients living with HIV
https://doi.org/10.1158/1078-0432.ccr-19-1266 Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
https://doi.org/10.1007/978-3-642-27994-2 Theranostics, Gallium-68, and Other Radionuclides
https://doi.org/10.1210/jc.2019-01204 Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma
https://doi.org/10.3390/diagnostics11040605 CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
https://doi.org/10.1159/000488510 Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours
https://doi.org/10.1093/annonc/mdv626 Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors